ArticleFrontiers in oncology2023

Anlotinib combined with Sintilimab is win-win cooperation for primary squamous cell carcinoma of the thyroid: A case report and literature review.

Zichang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.